Plain-English translation of NCT06720766 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is evaluating how well FibroScan—a non-invasive ultrasound-based imaging technique—can detect fatty liver disease and liver scarring in people with obesity. The study aims to figure out the best settings and thresholds for this scan specifically for Chinese patients, since current guidelines may not work perfectly for everyone.
FibroScan is already used in clinical practice to check liver health, but doctors aren't always sure how to interpret the results fairly for people with obesity, and the standard cut-off values may not work equally well across all populations. This study will help establish more accurate guidelines for this test.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will have a FibroScan examination (a painless ultrasound-based test that takes just a few minutes) along with your scheduled bariatric surgery and liver biopsy. These tests help doctors see how much fat and scarring is in your liver and will help establish better diagnostic standards for people like you. The study involves observing and comparing the results of these tests—you're not testing a new drug, but rather helping researchers refine how to use an existing imaging tool more accurately.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
China
Sponsor
The Third People's Hospital of Chengdu
Enrollment target
~600 participants
Started
October 2023
Primary completion
March 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Peisen Guo
The Third People's Hospital of Chengdu
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.